Zions Bancorporation's SWOT analysis: western bank's stock faces headwinds amid growth

Zions Bancorporation (ZION) is navigating a mixed financial landscape, with a year-to-date stock decline of 10.59% despite a "GOOD" financial health score. While the bank increased its dividend by 5% and initiated a $40 million share buyback, it faces challenges including a 32% increase in criticized loans and net interest income pressure from declining interest rates; however, the acquisition of four California branches is expected to boost loans and deposits by 1%, and analysts project potential NII growth if interest rates align with forward rates.

Analysis

Zions Bancorporation (ZION), with a market capitalization of $7.04 billion, presents a mixed financial profile as of May 28, 2025. The bank's stock, trading at $47.71, has experienced a 10.59% year-to-date decline, yet maintains a "GOOD" financial health score per InvestingPro. Revenue grew 6.44% in the last twelve months, and the P/E ratio stands at 9.27, with EPS estimates at $5.10 for FY2025 and $5.50 for FY2026. Strategically, Zions expanded by acquiring four California branches, adding approximately $700 million in deposits and $400 million in loans. However, significant concerns exist regarding loan portfolio quality; criticized loans rose 32% in early 2025 (C&I up 27%, CRE up 39%), and classified loans increased 38%, notably in multifamily. The $1.8 billion office loan segment, representing 3.2% of total loans, is particularly concerning, with 43% maturing in 2025 and an ACL of 3.9%. Net interest income (NII) has been pressured by interest rate movements, declining 4.1% in Q1 2025 following a 100 bps rate decrease, after a 4.5% drop in the prior quarter. Projections suggest NII could grow 6.8% YoY by Q4 2025 if rates align with forward rates. Management has shown confidence through a 5% dividend increase in Q4 2024 (yielding 3.61%) and a new $40 million share buyback program. Analyst sentiment is divided: Barclays maintains an "Underweight" rating with a $61 price target, while Goldman Sachs issued a "Buy" rating in January 2025. InvestingPro's Fair Value model suggests the stock is slightly undervalued.

Key Decisions for Investors

• Investors should closely monitor Zions' asset quality metrics, particularly the trajectory of criticized and classified loans in the C&I and CRE sectors, given the reported 32% and 38% increases respectively, and the refinancing risk associated with the $1.8 billion office loan portfolio where 43% matures in 2025.
• Carefully evaluate the bank's sensitivity to interest rate fluctuations, as a 100 bps rate decrease led to a 4.1% NII decline in Q1 2025, while also considering the potential for NII growth if rates align with forward projections.
• Weigh the potential benefits from the California branch acquisition, which is expected to increase loans and deposits by 1%, and the focus on SME lending against the significant risks from deteriorating loan quality and interest rate headwinds.
• Consider the management's capital return initiatives, including a 5% dividend increase and a $40 million share buyback, and InvestingPro's 'slightly undervalued' assessment, in the context of the stock's 10.59% YTD decline and divergent analyst ratings.